Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.63 - $0.83 $28,542 - $37,603
45,305 Added 305.87%
60,117 $46,000
Q3 2023

Nov 14, 2023

BUY
$0.6 - $0.85 $8,887 - $12,590
14,812 New
14,812 $11,000
Q4 2022

Feb 14, 2023

BUY
$0.71 - $1.0 $117,473 - $165,455
165,455 New
165,455 $125,000
Q2 2022

Aug 15, 2022

SELL
$0.87 - $1.18 $7,777 - $10,549
-8,940 Reduced 6.52%
128,149 $120,000
Q1 2022

May 16, 2022

SELL
$0.99 - $1.3 $82,265 - $108,024
-83,096 Reduced 37.74%
137,089 $159,000
Q4 2021

Feb 14, 2022

BUY
$1.2 - $1.62 $191,440 - $258,445
159,534 Added 263.04%
220,185 $270,000
Q3 2021

Nov 15, 2021

BUY
$1.25 - $2.59 $59,156 - $122,571
47,325 Added 355.13%
60,651 $92,000
Q4 2020

Feb 16, 2021

BUY
$1.06 - $1.74 $14,125 - $23,187
13,326 New
13,326 $18,000
Q3 2020

Nov 16, 2020

SELL
$1.02 - $1.42 $32,560 - $45,329
-31,922 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$0.42 - $1.98 $13,407 - $63,205
31,922 New
31,922 $56,000

Others Institutions Holding RWLK

About ReWalk Robotics Ltd.


  • Ticker RWLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 62,823,200
  • Market Cap $319M
  • Description
  • ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by para...
More about RWLK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.